Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Purified recombinant EBV desoxyribonuclease in serological diagnosis of nasopharyngeal carcinoma.

Stolzenberg MC, Debouze S, Ng M, Sham J, Choy D, Bouguermouh A, Chan KH, Ooka T.

Int J Cancer. 1996 May 3;66(3):337-41.

2.

Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.

Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.

J Med Virol. 2007 Nov;79(11):1710-21.

PMID:
17854043
3.
5.

Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.

Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM.

J Clin Virol. 2008 Aug;42(4):343-52. doi: 10.1016/j.jcv.2008.03.006. Epub 2008 May 1.

PMID:
18455473
6.

Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.

Shu CH, Tu TY, Lin LS, Ro LH, Lo MS, Huang CH, Chen KY, Liu WT.

Zhonghua Yi Xue Za Zhi (Taipei). 1999 Jun;62(6):350-5.

PMID:
10389292
7.

Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma.

Liu MY, Shih YY, Chou SP, Chen CJ, Sheen TS, Yang CS, Chen JY.

J Med Virol. 1998 Nov;56(3):179-85.

PMID:
9783682
8.

IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of nasopharyngeal carcinoma.

Sigel G, Schillinger M, Henninger K, Bauer G.

J Med Virol. 1994 Jul;43(3):222-7.

PMID:
7931181
9.

EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.

Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH.

Int J Cancer. 2003 Jul 10;105(5):706-9.

10.
11.

Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.

Feng P, Chan SH, Soo MY, Liu D, Guan M, Ren EC, Hu H.

Cancer. 2001 Oct 1;92(7):1872-80.

PMID:
11745260
12.

Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.

Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, Frikha M, Jlidi R, Middeldorp JM.

J Med Virol. 2005 Apr;75(4):593-602.

PMID:
15714486
13.

Study on sero-diagnosis of nasopharyngeal carcinoma using a dual antibody test against recombinant Epstein-Barr virus antigens.

Gu YL, Zhang CQ, Ng SP, Zong YS, Liang YJ, Chen YL.

Ai Zheng. 2003 Sep;22(9):903-6.

PMID:
12969518
14.

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

15.

Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.

Dardari R, Khyatti M, Benider A, Jouhadi H, Kahlain A, Cochet C, Mansouri A, El Gueddari B, Benslimane A, Joab I.

Int J Cancer. 2000 Apr 1;86(1):71-5.

16.

Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.

Liu MY, Huang YT, Sheen TS, Chen JY, Tsai CH.

J Med Virol. 2004 Aug;73(4):574-82.

PMID:
15221902
17.

The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).

Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.

Cancer Detect Prev. 1981;4(1-4):307-12.

PMID:
6299561
18.
19.

Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.

Hoebe EK, Hutajulu SH, van Beek J, Stevens SJ, Paramita DK, Greijer AE, Middeldorp JM.

Clin Vaccine Immunol. 2011 Feb;18(2):298-304. doi: 10.1128/CVI.00193-10. Epub 2010 Dec 1.

20.

Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.

Gu AD, Lu LX, Xie YB, Chen LZ, Feng QS, Kang T, Jia WH, Zeng YX.

J Transl Med. 2009 Aug 23;7:73. doi: 10.1186/1479-5876-7-73.

Supplemental Content

Support Center